Drug Type Synthetic peptide |
Synonyms- |
Target |
Action- |
Mechanism DPP-4 inhibitors(Dipeptidyl peptidase IV inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Diabetes Mellitus, Type 2 | Discovery | - | 17 May 2024 | |
| Diabetes Mellitus, Type 2 | Discovery | - | 17 May 2024 | |
| Kidney Diseases | Discovery | - | 17 May 2024 | |
| Kidney Diseases | Discovery | - | 17 May 2024 | |
| Liver Diseases | Discovery | - | 17 May 2024 | |
| Liver Diseases | Discovery | - | 17 May 2024 |





